vs
AVINO SILVER & GOLD MINES LTD（ASM）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
AVINO SILVER & GOLD MINES LTD的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$21.0M vs $19.6M），AVINO SILVER & GOLD MINES LTD净利率更高（36.6% vs -177.4%，领先214.0%），AVINO SILVER & GOLD MINES LTD同比增速更快（44.0% vs -11.5%），过去两年AVINO SILVER & GOLD MINES LTD的营收复合增速更高（51.1% vs -12.2%）
阿维诺金银矿业有限公司是一家加拿大矿业企业，主要从事银、金、铜等贵金属及基本金属的勘探、开发与生产，核心运营资产为位于墨西哥杜兰戈州的旗舰阿维诺矿区，产品供应全球大宗商品市场。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ASM vs LAB — 直观对比
营收规模更大
ASM
是对方的1.1倍
$19.6M
营收增速更快
ASM
高出55.4%
-11.5%
净利率更高
ASM
高出214.0%
-177.4%
两年增速更快
ASM
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.0M | $19.6M |
| 净利润 | $7.7M | $-34.7M |
| 毛利率 | 47.1% | 48.5% |
| 营业利润率 | — | -168.5% |
| 净利率 | 36.6% | -177.4% |
| 营收同比 | 44.0% | -11.5% |
| 净利润同比 | 558.9% | -28.8% |
| 每股收益（稀释后） | $0.05 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMLAB
| Q3 25 | $21.0M | $19.6M | ||
| Q2 25 | $21.8M | $21.8M | ||
| Q1 25 | $18.8M | $40.8M | ||
| Q3 24 | $14.6M | $22.1M | ||
| Q2 24 | $14.8M | $22.5M | ||
| Q1 24 | $12.4M | $45.5M | ||
| Q4 23 | — | $28.2M | ||
| Q3 23 | $12.3M | $25.4M |
净利润ASMLAB
| Q3 25 | $7.7M | $-34.7M | ||
| Q2 25 | $2.9M | $-33.5M | ||
| Q1 25 | $5.6M | $-26.0M | ||
| Q3 24 | $1.2M | $-26.9M | ||
| Q2 24 | $1.2M | $-45.7M | ||
| Q1 24 | $599.0K | $-32.2M | ||
| Q4 23 | — | $-19.8M | ||
| Q3 23 | $-803.0K | $-21.0M |
毛利率ASMLAB
| Q3 25 | 47.1% | 48.5% | ||
| Q2 25 | 46.9% | 48.8% | ||
| Q1 25 | 56.1% | 48.4% | ||
| Q3 24 | 39.1% | 54.9% | ||
| Q2 24 | 31.8% | 46.1% | ||
| Q1 24 | 18.9% | 53.1% | ||
| Q4 23 | — | 47.6% | ||
| Q3 23 | 19.2% | 44.0% |
营业利润率ASMLAB
| Q3 25 | — | -168.5% | ||
| Q2 25 | — | -118.1% | ||
| Q1 25 | — | -80.8% | ||
| Q3 24 | — | -120.9% | ||
| Q2 24 | — | -134.5% | ||
| Q1 24 | — | -132.2% | ||
| Q4 23 | — | -75.9% | ||
| Q3 23 | — | -83.5% |
净利率ASMLAB
| Q3 25 | 36.6% | -177.4% | ||
| Q2 25 | 13.1% | -153.7% | ||
| Q1 25 | 29.8% | -63.8% | ||
| Q3 24 | 8.0% | -122.0% | ||
| Q2 24 | 8.4% | -203.3% | ||
| Q1 24 | 4.8% | -70.6% | ||
| Q4 23 | — | -70.2% | ||
| Q3 23 | -6.5% | -82.8% |
每股收益（稀释后）ASMLAB
| Q3 25 | $0.05 | $-0.09 | ||
| Q2 25 | $0.02 | $-0.09 | ||
| Q1 25 | $0.04 | $-0.07 | ||
| Q3 24 | $0.01 | $-0.07 | ||
| Q2 24 | $0.01 | $-0.12 | ||
| Q1 24 | $0.00 | $-0.27 | ||
| Q4 23 | — | $-0.24 | ||
| Q3 23 | $-0.01 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.3M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.1M | $399.7M |
| 总资产 | $221.9M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMLAB
| Q3 25 | $57.3M | $129.4M | ||
| Q2 25 | $37.3M | $158.6M | ||
| Q1 25 | $26.6M | $150.9M | ||
| Q3 24 | $7.8M | $210.6M | ||
| Q2 24 | $5.3M | $269.8M | ||
| Q1 24 | $3.5M | $287.1M | ||
| Q4 23 | — | $51.7M | ||
| Q3 23 | $1.9M | $79.7M |
总债务ASMLAB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M | ||
| Q4 23 | — | $63.5M | ||
| Q3 23 | — | $64.6M |
股东权益ASMLAB
| Q3 25 | $182.1M | $399.7M | ||
| Q2 25 | $144.8M | $424.5M | ||
| Q1 25 | $132.3M | $454.6M | ||
| Q3 24 | $114.5M | $489.3M | ||
| Q2 24 | $112.2M | $510.3M | ||
| Q1 24 | $107.8M | $577.3M | ||
| Q4 23 | — | $-148.1M | ||
| Q3 23 | $102.7M | $-131.7M |
总资产ASMLAB
| Q3 25 | $221.9M | $539.6M | ||
| Q2 25 | $174.7M | $557.0M | ||
| Q1 25 | $157.7M | $579.6M | ||
| Q3 24 | $135.4M | $681.5M | ||
| Q2 24 | $133.7M | $708.7M | ||
| Q1 24 | $128.6M | $777.7M | ||
| Q4 23 | — | $323.1M | ||
| Q3 23 | $123.5M | $339.3M |
负债/权益比ASMLAB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | 1.08× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流ASMLAB
| Q3 25 | $8.3M | $-22.2M | ||
| Q2 25 | $8.3M | $-20.7M | ||
| Q1 25 | $758.0K | $-30.3M | ||
| Q3 24 | $4.1M | $-27.9M | ||
| Q2 24 | $1.1M | $-39.0M | ||
| Q1 24 | $2.3M | $-62.5M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | $-83.0K | $-11.4M |
自由现金流ASMLAB
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | — | $-12.3M |
自由现金流率ASMLAB
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% | ||
| Q4 23 | — | -50.2% | ||
| Q3 23 | — | -48.6% |
资本支出强度ASMLAB
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 0.3% | ||
| Q3 23 | — | 3.6% |
现金转化率ASMLAB
| Q3 25 | 1.08× | — | ||
| Q2 25 | 2.92× | — | ||
| Q1 25 | 0.13× | — | ||
| Q3 24 | 3.55× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 3.92× | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASM
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
